A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection
about
Rabies virus glycoprotein as a carrier for anthrax protective antigenInduction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathwaysCharacterization of a single-cycle rabies virus-based vaccine vector.Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells.Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodiesSecond-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenicInvestigating the role for IL-21 in rabies virus vaccine-induced immunity.Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA VirusesChimeric newcastle disease virus protects chickens against avian influenza in the presence of maternally derived NDV immunityRhabdovirus-based vaccine platforms against henipavirusesImmunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge.Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirusVaccines for lyssaviruses other than rabies.Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread.A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes.Axonal and subcellular labelling using modified rabies viral vectors.
P2860
Q28391261-FCE8BEF8-F1B8-4A9C-A3FF-9290DE09B5F0Q28397551-E94709F1-842E-4C19-969F-8C38C80B30F5Q33676502-AD5A7E13-7E9B-4FE6-8322-767A31F5C743Q33854615-1E2085AA-36CF-420D-9303-3FBB223D4E25Q34327387-A6F49B02-C68F-47B6-B974-264EDA611444Q34334320-B4A50DB5-6C09-4390-B8E6-A67DFB9ACC73Q34338054-E25DB3A4-33C6-4111-9EAB-5595730FC739Q34461764-8C63031A-E43F-461B-80CD-986AC478B501Q34630598-A4C4F88F-134C-45B3-9946-9EB00B332334Q34806497-427C0A05-DC50-475C-9A6A-C7D69481E931Q34983940-CD0A0DC2-5A0E-4B68-A924-1AAD1352535FQ34992537-7F055E9F-7F89-46A6-8C01-C924BF2139F8Q35043107-4669647E-5ECE-4B80-94DC-B8FD04B29A8BQ35275167-B432B50F-8F52-41DB-A99C-8E18A5903FB2Q35857789-5517511E-5E5C-4435-85A8-69E452A9069EQ36238718-676DFAEB-662F-4C47-8D10-452CDC44E16CQ36474235-CD0F9766-F3F4-4C4D-9C07-940A4BE6E9C1Q36483804-F8CC7766-25E5-4759-AEEB-D12582F7AA93Q36559952-80AF99C4-46B3-49B1-8AB0-0482DF8BDA28Q37059997-2C8EB52F-330A-434B-A5DA-0BE7A25B0B53Q42276697-67111DCD-558B-498F-A14A-422DD69811B5
P2860
A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
A recombinant rabies virus exp ...... against rabies virus infection
@ast
A recombinant rabies virus exp ...... against rabies virus infection
@en
type
label
A recombinant rabies virus exp ...... against rabies virus infection
@ast
A recombinant rabies virus exp ...... against rabies virus infection
@en
prefLabel
A recombinant rabies virus exp ...... against rabies virus infection
@ast
A recombinant rabies virus exp ...... against rabies virus infection
@en
P2093
P2860
P356
P1476
A recombinant rabies virus exp ...... against rabies virus infection
@en
P2093
B Dietzschold
J P McGettigan
M J Schnell
P2860
P304
14680-14685
P356
10.1073/PNAS.011510698
P407
P577
2000-12-01T00:00:00Z